These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10631952)

  • 1. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
    Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
    Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
    Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
    EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
    Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
    Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
    Vogt AB; Kropshofer H; Hämmerling GJ
    Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
    van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
    Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional HLA-DM on the surface of B cells and immature dendritic cells.
    Arndt SO; Vogt AB; Markovic-Plese S; Martin R; Moldenhauer G; Wölpl A; Sun Y; Schadendorf D; Hämmerling GJ; Kropshofer H
    EMBO J; 2000 Mar; 19(6):1241-51. PubMed ID: 10716924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion.
    vogt AB; Moldenhauer G; Hämmerling GJ; Kropshofer H
    Immunol Lett; 1997 Jun; 57(1-3):209-11. PubMed ID: 9232453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
    Schulze MS; Wucherpfennig KW
    Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of peptide repertoire selection by HLA-DM.
    Pos W; Sethi DK; Wucherpfennig KW
    Trends Immunol; 2013 Oct; 34(10):495-501. PubMed ID: 23835076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide exchange in MHC molecules.
    Jensen PE; Weber DA; Thayer WP; Westerman LE; Dao CT
    Immunol Rev; 1999 Dec; 172():229-38. PubMed ID: 10631949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest?
    Kropshofer H; Hämmerling GJ; Vogt AB
    Immunol Today; 1997 Feb; 18(2):77-82. PubMed ID: 9057358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation.
    Alfonso C; Liljedahl M; Winqvist O; Surh CD; Peterson PA; Fung-Leung WP; Karlsson L
    Immunol Rev; 1999 Dec; 172():255-66. PubMed ID: 10631951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.
    Wubbolts R; Neefjes J
    Immunol Rev; 1999 Dec; 172():189-208. PubMed ID: 10631947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation by HLA-DO of MHC class II-restricted antigen processing.
    Denzin LK; Sant'Angelo DB; Hammond C; Surman MJ; Cresswell P
    Science; 1997 Oct; 278(5335):106-9. PubMed ID: 9311912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.
    Afridi S; Hoessli DC; Hameed MW
    Immunol Rev; 2016 Jul; 272(1):151-68. PubMed ID: 27319349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trafficking of major histocompatibility complex class II molecules through intracellular compartments containing HLA-DM.
    Robbins NF; Hammond C; Denzin LK; Pan M; Cresswell P
    Hum Immunol; 1996 Jan; 45(1):13-23. PubMed ID: 8655355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of the MHC class II-associated peptide repertoire by HLA-DM.
    Arndt SO; Vogt AB; Hämmerling GJ; Kropshofer H
    Immunol Res; 1997; 16(3):261-72. PubMed ID: 9379076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DM acts as a molecular chaperone and rescues empty HLA-DR molecules at lysosomal pH.
    Kropshofer H; Arndt SO; Moldenhauer G; Hämmerling GJ; Vogt AB
    Immunity; 1997 Mar; 6(3):293-302. PubMed ID: 9075930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.